These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6402528)

  • 1. Position paper--PUVA therapy. American Academy of Dermatology.
    Bickers DR
    J Am Acad Dermatol; 1983 Feb; 8(2):265-70. PubMed ID: 6402528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoralen photochemotherapy.
    Gupta AK; Anderson TF
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):703-34. PubMed ID: 3316316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimising the risks of PUVA treatment.
    van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemotherapy in psoriasis and other skin diseases.
    Adrian RM
    Am Fam Physician; 1981 May; 23(5):95-100. PubMed ID: 7234635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental UVA radiation and eye protection during PUVA therapy.
    Morison WL; Strickland PT
    J Am Acad Dermatol; 1983 Oct; 9(4):522-5. PubMed ID: 6630614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side-effects of psoralen photochemotherapy (PUVA).
    Wolff K
    Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
    El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
    Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phototherapy and photochemotherapy in dermatologic diseases.
    Rajatanavin N; Scharf MJ; Bernhard JD
    Compr Ther; 1988 Oct; 14(10):11-8. PubMed ID: 3053012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits and risks of long-term PUVA photochemotherapy.
    Momtaz K; Fitzpatrick TB
    Dermatol Clin; 1998 Apr; 16(2):227-34. PubMed ID: 9589196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of vitiligo after psoralens and ultraviolet a therapy.
    Todes-Taylor N; Abel EA; Cox AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):526-32. PubMed ID: 6630615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal squamous cell carcinoma following whole body electron beam therapy and photochemotherapy for mycosis fungoides.
    Wright S; Kennedy C
    Clin Exp Dermatol; 1984 Jan; 9(1):53-7. PubMed ID: 6420097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemotherapy beyond psoriasis.
    Honig B; Morison WL; Karp D
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):775-90. PubMed ID: 7929924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
    Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
    Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.